Overview

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare 2 combination drug therapies in HIV-infected patients who have never received anti-HIV treatment.
Phase:
N/A
Details
Lead Sponsor:
Glaxo Wellcome
Treatments:
Abacavir
Amprenavir
Lamivudine
Lamivudine, zidovudine drug combination
Nelfinavir
Zidovudine